Alan Raises €480M Series G for Prevention Insurance

Alan raised €480M Series G led by Prosus for its integrated health insurance and prevention platform. The round values the company at €5.5B.

Emel Kavaloglu

Alan (alan.com), a Paris-based provider of integrated health insurance, prevention programs, and virtual care, has raised €480 million ($553 million) in Series G funding led by Prosus. The company operates as Europe's first new independent health insurer licensed in France since 1986, combining licensed insurance with an AI-powered medical assistant, telemedicine, and gamified prevention tools. The capital will accelerate international expansion and AI product development.

Prosus Backs Prevention Insurance Strategy

The timing follows Alan's €100 million round three months earlier at a €5 billion valuation. Prosus committed €400 million of the new round, with participation from Teachers' Venture Growth, Index Ventures, and Dara Holdings. The round values Alan at €5.5 billion and brings total funding above €1.2 billion. Prosus gains access to Alan's health data capabilities while providing its Large Commerce Model for AI development.

Fragmented European Systems Favor Integrated Players

European health insurance markets remain highly fragmented across borders, languages, and regulations. Traditional insurers have struggled to deliver digital-first experiences, creating space for a vertically integrated platform that manages insurance risk, care navigation, and prevention in one app. Alan reports 90 percent member satisfaction and processes 70 percent of reimbursements in under five minutes.

AI Assistant Drives Member Engagement

Alan's Mo AI medical assistant now serves more than 500,000 members and records 81 percent patient preference over traditional consultations. The company published the first large-scale study of conversational medical AI in real clinical settings, showing 95 percent doctor approval. Its flat organizational structure and written culture have compounded ten years of documentation into an internal AI knowledge agent used across the company.

"Health can't wait for symptoms to get worse, for a six-month appointment, or for the system to evolve on its own." — Jean-Charles Samuelian-Werve, CEO

Mission Capital Signals Global Ambition

Prosus's dominant investment reflects conviction in AI-led healthcare transformation at scale. The deal includes both primary and secondary shares, providing liquidity while funding growth. Alan's CEO also serves as a co-founding advisor and board member at Mistral AI, giving the company direct ties to Europe's leading AI lab.

Digital Health Funding Accelerates in Europe

The European digital health market reached $69.61 billion in 2024 and is projected to grow to $304.46 billion by 2032. Alan now serves 1.1 million members across France, Belgium, Spain, and Canada, generating €804 million ARR with 50 percent-plus year-over-year growth. France operations have reached EBITDA profitability.

National Champion Status Draws Elite Backing

French President Emmanuel Macron publicly endorsed Alan as an ambitious, profitable European tech champion. Celebrity investors including Kylian Mbappé and Blaise Matuidi have also joined the cap table or endorsed the platform, underscoring cultural validation beyond traditional venture circles.

TAMradar monitors companies, people, and industries so you never miss important updates - tracking funding rounds, new hires, job openings, and 20+ signals.

Request access to get insights like this via webhooks or email.

Request access →

Index